WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsHeart Test Laboratories Inc. Common Stock (HSCS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 241972207% more annual revenue ($20.98B vs $8,670). GEHC leads profitability with a 9.1% profit margin vs 0.0%. GEHC earns a higher WallStSmart Score of 57/100 (C).

GEHC

Buy

57

out of 100

Grade: C

Growth: 4.0Profit: 6.0Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34

HSCS

Avoid

28

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 5.0Quality: 3.0
Piotroski: 1/9Altman Z: -32.10

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC2 strengths · Avg: 8.0/10
P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

HSCS2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
654.0%10/10

Revenue surging 654.0% year-over-year

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Areas to Watch

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.844/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-30.9%2/10

Earnings declined 30.9%

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

HSCS4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$6.18M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Debt/EquityHealth
1.463/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio, Price/Book.

Bull Case : HSCS

The strongest argument for HSCS centers on Revenue Growth, Price/Book. Revenue growth of 654.0% demonstrates continued momentum.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.

Bear Case : HSCS

The primary concerns for HSCS are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

GEHC profiles as a value stock while HSCS is a hypergrowth play — different risk/reward profiles.

HSCS carries more volatility with a beta of 1.97 — expect wider price swings.

HSCS is growing revenue faster at 654.0% — sustainability is the question.

GEHC generates stronger free cash flow (112M), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (57/100 vs 28/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Heart Test Laboratories Inc. Common Stock

HEALTHCARE · MEDICAL DEVICES · USA

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company is headquartered in Southlake, Texas.

Visit Website →

Want to dig deeper into these stocks?